PLA2G2A and Alzheimer disease: One group of the PLA2s which has been considered as an attractive drug target for the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD), is calcium-dependent cytosolic phospholipases A2 (cPLA2s) [3].